Dr. Trolice moderated a live global webinar sponsored by the American Society for Reproductive Medicine (ASRM), where they discussed preimplantation genetic testing (PGT) for Aneuploidy: Debating Universal vs. Discretionary Use.

“Preimplantation genetic testing for aneuploidy (PGT-A) has been touted as a major step toward the holy grail by some vs. an unnecessary up-charge by others. This webinar will be an engaging spirited debate of these opposing views.”

The field of assisted reproductive technology continues to advance by improving methods to optimize outcomes for infertility patients. The “holy grail” is the ability to identify an embryo identified by testing to maximize its ability to implant.